1. Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist. Issue 7 (21st May 2018) Authors: Erstad, Derek J.; Farrar, Christian T.; Ghoshal, Sarani; Masia, Ricard; Ferreira, Diego S.; Chen, Yin‐Ching Iris; Choi, Ji‐Kyung; Wei, Lan; Waghorn, Phillip A.; Rotile, Nicholas J.; Tu, Chuantao; Graham‐O'Regan, Katherine A.; Sojoodi, Mozhdeh; Li, Shen; Li, Yang; Wang, Guogiang; Corey, Kathleen E... Journal: Hepatology communications Issue: Volume 2:Issue 7(2018) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction. Issue 6 (18th March 2019) Authors: Li, Shen; Ghoshal, Sarani; Sojoodi, Mozhdeh; Arora, Gunisha; Masia, Ricard; Erstad, Derek J.; Ferriera, Diego S.; Li, Yang; Wang, Guogiang; Lanuti, Michael; Caravan, Peter; Or, Yat Sun; Jiang, Li-Juan; Tanabe, Kenneth K.; Fuchs, Bryan C. Journal: FASEB journal Issue: Volume 33:Issue 6(2019) Page Start: 7103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗